HTLV-II risk factors in native Americans in Florida

Neuroepidemiology

Volumn 18, Issue 1, 1999, Pages 37-47

  Lowis, George W ^a   Sheremata, William A ^a   Wickman, Patricia R ^b   Dube, Symalima ^c   Dube, Dipak K ^c   Poiesz, Bernard J ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Seminole Tribe of Florida ^*  (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Haplotypes; Human T cell lymphotropic virus type II; Mitochondrial DNA; Polymerase chain reaction; Restriction fragment length polymorphism; Risk factors; Seminole Indians

Indexed keywords

ADULT; AGED; AMERICAN INDIAN; ARTICLE; DNA DETERMINATION; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; DNA PRIMERS; DNA, MITOCHONDRIAL; FEMALE; FLORIDA; HTLV-II INFECTIONS; HUMANS; INDIANS, NORTH AMERICAN; MALE; MIDDLE AGED; POINT MUTATION; RISK FACTORS;

EID: 0032890167     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026194     Document Type: Article

References (73)

1. Dube DK, Sherman MP, Saksena NK, Bryz-Gornia V, Mendelsohn J, Love J, Arnold CB, Spicer T, Dube S, Glaser JB, Williams AE, Nishimuura M, Jacobsen S, Ferrer JF, Del-Pino N, Quiruelos S, Poiesz BJ: Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II. J Virol 1993;67:1175-1184.
2. Hall WW, Ishak R, Zhu SW, Novoa P, Eiraku N, Takahashi H, de Costa Ferreira M, Azevedo V, Ishak M, de Costa Ferreira O, Monken C, Kurata T: Human T lymphotropic virus type II (HTLV-II): Epidemiology, molecular properties, and clinical features of infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(suppl 1):S204-S214.
3. Murphy EL: The clinical epidemiology of human T-lymphotropic virus type II (HTLV-II). J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(suppl 1):S215-S219.
4. Dooneief G, Marlink R, Bell K, Marder K, Renjifo B, Stern Y, Mayeux R: Neurologic consequences of HTLV-II infection in injection-drug users. Neurology 1996; 46:1556-1560.
5. Lehky TJ, Flerlage N, Katz D, Houff S, Hall WH, Ishii K, Monken C, Dhib-Jalbut S, McFurland HF, Jacobson S: Human T-cell lymphotropic virus type II-associated myelopathy: Clinial and immunologic profiles. Ann Neurol 1996;40:704-723.
6. Ferreira OE Jr, Planelles V, Rosenblatt JD: Human T-cell leukemia viruses: Epidemiology, biology and pathogenesis. Blood Rev 1997;11: 91-104.
7. Hjelle B: Human T-cell leukemia/ lymphoma viruses: Life cycle, pathogenicity, epidemiology, and diagnosis. Arch Pathol Lab Med 1991;115:440-445.
8. Montgomery RD, Cruickshank EK, Robertson WB, McMenemey WH: Clinical and pathological observations on Jamaican neuropathy: A report of 206 cases. Brain 1964;87: 425-462.
9. Rosenblatt JD: Human T-lymphotropic virus type I and II. West J Med 1993;158:379-384.
10. Jacobsen S: Cellular immune response to HTLV-I: Immunopathogenic role in HTLV-I-associated neurologic disease. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(suppl 1):S100-S106.
11. Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G: Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992; 339:645-646.
12. Harrington WJ, Sheremata W, Hjelle B, Dube DK, Bradshaw P, Foung SKH, Snodgrass S, Toedter G, Cabral L, Poiesz BJ: Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 1993;33:411-414.
13. Sheremata W, Harrington WJ, Bradshaw PA, Foung SKH, Raffanti SP, Berger JR, Snodgrass S, Resnick L, Poiesz BJ: Association of (tropical) ataxic neuropathy with HTLV-II. Virus Res 1993;29:71-77.
14. Oger J, Lu T, Aziz T, Gasoyne RD, King EE, Cummings H, Paty DW, Ekaban GA: HTLV-II associated spinal cerebellar degeneration with high in-vitro proliferation, increased CD4+positive cells - No evidence of cell membrane activation. J Aids Hum Retroviruses 1995;10:228.
15. Manns A, Blattner WA: The epidemiology of the human T-cell lymphotropic virus type I and type II: Etiologic role in human disease. Transfusion 1991;31:67-75.
16. Hjelle B, Cyrus S, Swenson SG: Evidence for sexual transmission of human T-lymphotropic virus type II (letter). Ann Intern Med 1992;116: 90-91.
17. Ishak R, Harrington WJ, Azevedo VN, Eiraku N, Ishak MOG, Guerreiro JF, Santos SB, Kubo T, Monken C, Alexander S, Hall WW: Identification of human T-cell lymphotropic virus type IIa infection in the Kayapo, an indigeneous population of Brazil. AIDS Res Hum Retroviruses 1995;11:813-821.
18. Wiktor SZ, Cannon RO, Atkinson WL, Lutz B, Hook EW 3rd, Blattner WA, Quinn TC: Infection with human T-lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans. J Infect Dis 1992;165:920-924.
19. Lal RB, Owen SM, Seguardo AC, Gonora-Biachi RA: Mother to child transmission of human T-lymphotropic virus type II (HTLV-II). Ann Intern Med 1994;120:300-301.
20. Vitek CR, Gracia FI, Giusti RA, Fukuda K, Green DB, Castillo LC, Armien B, Khabbaz RF, Levine PH, Kaplan JE, Blattner WA: Evidence for sexual and mother to child transmission of human T lymphotropic virus type II among Guaymi Indians, Panama. J Infect Dis 1995; 171:1022-1026.
21. Nyambi PN, Ville Y, Louwagie J, Bedjabagu I, Glowaczower E, Peeters M, Kerouedan D, Dazza M, Larouze B, van der Groen G, Delaporte E: Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: A prospective follow-up of 4 years. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:187-192.
22. Lal RB, Gongora-Biachi RA, Pardi D, Switzer WM, Goldman I, Lal AA: Evidence for mother to child transmission of human T lymphotropic virus type II. J Infect Dis 1993;168:586-591.
23. Lal RB, Owens SM, Seguardo ACA, Gongora-Biachi RA: Mother to child transmission of human T-cell lymphotropic virus type II (HTLV-II). Ann Intern Med 1994;120:300-301.
24. Lee HH, Swanson P, Rosenblatt JD, Chen ISY, Sherwood WC, Smith DE, Tegtmeier GE, Fernando LP, Fang CT, Osame M, Kleinman SH: Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet 1991; 337:1435-1439.
25. Donegan E, Busch M, Galleshaw JA, Shaw GM, Mosley JW, the Transfusion Safety Study Group: Transfusion of blood components from a donor with human T-lymphotropic virus type II (HTLV-II) infection. Ann Intern Med 1990; 113:555-556.
26. Hjelle B, Mills R, Mertz G, Swenson S: Transmission of HTLV-II via blood transfusion. Vox Sang 1990; 59:119-122.
27. Rios M, Khabbaz RF, Kaplan JE, Hall WW, Kessler D, Bianco C: Transmission of human T-cell lymphotropic virus (HTLV) type II by transfusion of HTLV-I screened blood products. J Infect Dis 1994; 170:206-210.
28. Nogueira CM, Covalcunti M, Schechter M, Ferreira OC: Human T lymphotropic virus type I and II infections in healthy blood donors from Rio de Janeiro, Brazil (letter). Vox Sang 1996;70:47-48.
29. Ferreira OC Jr, Vas RS, Carvalho MB, Guerra C, Fabron AL, Rosemblit J, Hammerschlak N: Human T-cell lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from São Paulo, Brazil. Transfusion 1995;35:258-263.
30. Kwok S, Gallo RC, Hanson C, McKinney N, Poiesz B, Sninsky JJ: High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing. AIDS Res Hum Retroviruses 1990;6:561-565.
31. Khabbaz RF, Hartel D, Lairmore M, Horsburgh CR, Schoenbaum EE, Roberts B, Hartley TM, Friedland G: Human T-lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: An old infection? J Infect Dis 1991;163:252-256.
32. Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B, Kaplan JE: Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1992;326:375-380.
33. Lee H, Swanson P, Shorty VS, Zack JA, Rosenblatt JD, Chen IS: High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 1989;244:471-475.
34. Lee H, Weiss SH, Brown LS, Mildvan D, Shorty V, Saranolatz L, Chu A, Ginsburg HM, Markowitz N, Des Jarlais DC, Blattner WA, Allain JP: Patterns of HIV-I and HTLV-I/II in intravenous drug abusers from the middle Atlantic and central regions of the USA. J Infect Dis 1990;162: 347-352.
35. Robert-Guroff M, Weiss SH, Giron JA, Jennings AM, Ginzburg HM, Margolis IB, Blattner WA, Gatto RC: Prevalence of antibodies to HTLV-I, II and III in intravenous drug abusers from an Aids endemic region. JAMA 1986;255:3133-3137.
36. Page JB, Lai S, Chiturood DD, Klimas NG, Smith PC, Fletcher MA: HTLV-I/II seropositivity and death from AIDS among HIV-I seropositive intravenous drug users. Lancet 1990;335:1439-1441.
37. Soriano V, Gitierrez M, Merino F, Dronda F, Esparza B, Tuset C, the HTLV Spanish Study Group: Recent spread of human T lymphotropic virus type II among injecting drug users in Spain. HTLV Spanish Study Group (letter). J Infect Dis 1996;174:891-893.
38. Chironna M, Calabro ML, Quarto M, Germinario C, Fiore JR, Favero A, Potenza D, Chieco-Bianchi L, Barbuti S: HTLV-I and HTLV-II infections in subjects at risk for HIV-infection from southeastern Italy (Apulia region). Int J Cancer 1996; 65:746-750.
39. Schreiber GB, Murphy EL, Horton JA, Wright DJ, Garfein R, Chien HC, Nass CC: Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and II) in blood donors: The Retrovirus Epidemiology Donor Study. NHLBI Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14:263-271.
40. Gutfraind Z, Blejer JL, Saguier MC, Gomez Carretero ML, Pirola DA, Carreras Vescio LA: Evaluation of HTLV-I/II infection in blood donors in Buenos Aires. Medicina (B Aires) 1995;55:295-299.
41. Lee H, Swanson P, Rosenblatt JD, Chen ISY, Sherwood WC, Smith DE, Tegtmeier GE, Fernando LP, Fung CT, Osame M, Kleinman SH: Relative prevalence and risk factors of HTLV-I and HTLV-II infection in United States blood donors. Lancet 1991;337:1435-1439.
42. Levine PH, Blattner WA, Clark J, Tarone R, Maloney EM, Murphy EM, Gallo RC, Robert-Guroff M, Saxinger WC: Geographic distribution of HTLV-I and identification of a new high risk population. Int J Cancer 1988;42:7-12.
43. Levine PH, Jacobson S, Elliot R, Cavallero A, Colclough C, Dorry C, Stephenson C, Knigge RM, Drummond J, Nishimura M, Taylor ME, Wiktor S, Shaw GM: HTLVII infection in Florida Indians. AIDS Res Hum Retroviruses 1993;9:123-127.
44. Hjelle B, Scalf R, Swenson S: High frequency of human T-cell leukemia/lymphoma virus type II infection in New Mexico blood donors: Determination by sequence-specific oligonucleotide hybridization. Blood 1990;76:450-454.
45. Maloney EM, Biggar RJ, Nell JV, Taylor ME, Hahn BH, Shaw GM, Blattner WA: Endemic human T-cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis 1992;166:100-107.
46. Black FL, Biggar RF, Neel JV: High HTLV antibody prevalence in older women may reflect delayed appearance of positive reactions: Data on Brazilian Indians (abstract W 36). Proc 5th Int Conf Hum Retrovirol, Kumamoto, Japan, 1992.
47. Black FL, Biggar RJ, Neel JV, Maloney EM, Waters DJ: Endemic transmission of HTLV-type II among Kayapo Indians of Brazil. AIDS Res Hum Retroviruses 1994; 10:1165-1171.
48. Reeves WC, Levine PH, Cuevas M, Quiroz E, Maloney E, Saxinger WC: Seroepidemiology of human T-cell lymphotropic virus in the Republic of Panama. Am J Trop Med Hyg 1990;42:374-379.
49. Reeves WC, Cutler JR, Gracia F, Kaplan JE, Castillo L, Hartley TM, Brenes MM, Larreategui M, Loo de Lao S, Archbold C, Lairmore MD, Levine PH: Human T-cell lymphotropic virus infection in Guaymi Indians from Panama. Am J Trop Med Hyg 1990;43:410-418.
50. Heneine W, Kaplan JE, Gracia F, Lal RB, Roberts B, Levine PH, Reeves WC: HTLV-II endemicity among Guaymi Indians in Panama. N Engl J Med 1991;324:565.
51. Lairmore MD, Jacobson S, Gracia F, De BE, Castillo L, Larreategui M, Robert BD, Levine PH, Blattner WA, Kaplan JE: Isolation of human T lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci USA 1990;87:8840-8844.
52. Pardi D, Switzer WM, Hadlock KG, Kaplan JE, Lal RB, Folks TM: Complete nucleotide sequence of an Amerindian human T-cell lymphotropic virus type II (HTLV-II) isolate: Identification of a variant HTLV-II subtype b from a Guaymi Indian. J Virol 1993;67:4659-4664.
53. Fujiyama C, Fujiyoshi T, Miura T, Yashiki S, Matsumoto D, Zaninovic V, Blanco O, Harrington WJ, Byrnes JJ, Hayami M, Tajima K, Sonoda S: A new endemic focus of human T lymphotropic virus type II carriers among Orinoco natives in Columbia. J Infect Dis 1993;168:1075-1077.
54. Duenas-Barajas E, Bernal JE, Vaught DR, Briceno I, Duran C, Yanagihara R, Gajdusek DC: Co-existence of human T lymphotropic virus types I and II among the Wayuu Indians from the Guajira region of Columbia. AIDS Res Hum Retroviruses 1992;8:1851-1855.
55. Duenas-Barajas E, Bernal JE, Vaught DR, Nerurkar VR, Sarmiento P, Yanagihara R: Human retroviruses in Amerindians of Columbia: High prevalence of human T-cell lymphotropic virus type II infection among the Tunebo Indians. Am J Trop Med Hyg 1993;49:657-663.
56. Zaninovic V, Sanzon F, Lopez F, Velandia G, Blank A, Fujiyoshi T, Chan L, Sawada T, Miura T, Hayani M, Tajima K, Sonoda S: Geographic independence of HTLV-I and HTLV-II foci in the Andes highland, the Atlantic coast, and the Orinoco of Colombia. AIDS Res Hum Retroviruses 1994;10:97-105.
57. Ijichi S, Zaninovic V, Fidias E, Leon S, Katahira Y, Sonada S, Miura T, Hayami M, Hall WW: Identification of human T-cell leukemia virus type II infection in the Wayuu, an aboriginal population of Colombia. Jpn J Cancer Res 1993;84:1215-1218.
58. Ferrer JF, Del Pino N, Esteban E, Sherman MP, Dube S, Dube DK, Basombrio MA, Pimentel E, Segovia A, Quirulas S, Poiesz BJ: High rate of infection with the human T-cell leukemia retrovirus type II in four Indian populations of Argentina. Virology 1993;197:576-584.
59. Biglione M, Gessain A, Quiruelas S, Fay O, Taborda MA, Fernandez E, Lupo S, Panzita A, de The G: Endemic HTLV-II infection among Toba and Matacos Amerindians from north Argentina. J Acquir Immune Def Syndr 1993;6:631-632.
60. Echeverria de Perez G, Leóne-Ponte M, Noya O, Botto C, Gallo D, Bianco N: First description of endemic HTLV-II infection among Venezuelan Amerindians. J Acquir Immune Def Syndr 1993;6:1368-1372.
61. Cartier L, Araya F, Castillo JL, Zaninovic V, Hayami M, Miura T, Imai J, Sonoda S, Shiraki H, Miyamoto K, Tajima K: Southernmost carriers of HTLV-I/II in the world. Jpn J Cancer Res 1993;84:1-3.
62. Leon-Ponte M, Echeverria de Perez G, Bianco N, Hengst J, Dube S, Love J, Poiesz BJ: Endemic infection with human T-cell leukemia/ lymphoma virus type IIb in Venezuelan Indians. J AIDS Hum Retroviruses, in press.
63. Huoponen K, Torroni A, Wickman PR, Sellitto D, Gurley DS, Scozzari R, Wallace DC: Mitochondrial DNA and Y chromosome-specific polymorphisms in the Seminole Tribe of Florida. Eur J Hum Genet 1997;5:25-34.
64. Centers for Disease Control: Licensure of screening tests for antibody to human T-lymphotropic virus type I. MMWR 1988;37:736-740, 745-747.
65. Saxinger C, Gallo RC: Applications of the indirect Elisa microtest to the detection and surveillance of human T-cell leukemia virus HTLV. Lab Invest 1983;49:371-372.
66. Madeleine MM, Wiktor SZ, Goedert JJ, Manns A, Levine PH, Biggar RJ, Blattner WA: HTLV-I and HTLV-II worldwide distribution: Reanalysis of 4,832 immunoblot results. Int J Cancer 1993;54:255-260.
67. Wattel E, Mariotti M, Agis F, Gordien E, Prou O, Courouce AM, Rouger P, Wain-Hobson S, Chen ISY, Lefrère JJ: Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II seropositive blood donors of the French West Indies. J Infect Dis 1992;165:369-372.
68. Ehrlich GD, Greenberg S, Abbott MA: Detection of human T-cell lymphoma/leukemia viruses; in Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds): PCR Protocols: A Guide to Methods and Applications. San Diego, Academic Press, 1990, pp 324-336.
69. Kwok S, Kellogg D, Ehrlich G, Poiesz BJ, Bhagavati S, Sninsky JJ: Characterization of a sequence of human T-cell leukemia virus type I from a patient with chronic progressive myelopathy. J Infect Dis 1988; 158:1193-1197.
70. Dube S, Spicer T, Bryz-Gornia V, Jones B, Dean T, Love J, Ferrer J, Esteban N, Harrington WJ, Glaser J, Dube DK, Williams A, Dosik H, Siegal F, Poiesz BJ: A rapid and sensitive method of identification of HTLV-II subtypes. J Med Virol 1995;45:1-9.
71. Torroni A, Schurr TG, Cabell MF, Brown MD, Neel JV, Larsen M, Smith DG, Vullo CM, Wallace DC: Asian affinities and continental radiation of the four founding Native American mtDNAs. Am J Hum Genet 1993;53:563-590.
72. Switzer WM, Pieniazek D, Swanson P, Samdal HH, Soriano V, Khabbaz RF, Kaplan JE, Lal RB, Heneine W: Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J Virol 1995;69:621-632.
73. Switzer WM, Owen SM, Pieniazek DA, Nerurkar VR, Duenas-Barajas E, Heneine W, Lal RB: Molecular analysis of human T-cell lymphotropic virus type II from Wayuu Indians of Colombia demonstrates two subtypes of HTLV-IIb. Virus Genes 1995;10:153-162.